Results 191 to 200 of about 8,226 (210)
Some of the next articles are maybe not open access.
Republished: Left atrial appendage occlusion
Postgraduate Medical Journal, 2015ABSTRACTLeft atrial appendage (LAA) occlusion for stroke and thromboembolism prevention in patients with atrial fibrillation (AF) represents a significant advancement in the field of cardiovascular disease. Prevention and avoidance of the devastating consequences of thromboembolic complications from AF continues to be central in the management of these
Oluseun, Alli, David, Holmes
openaire +2 more sources
Left Atrial Appendage Occlusion
Interventional Cardiology Clinics, 2018Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting 1.5–2% of the general population and more than 8% of those older than 80 years. Because of the progressive ageing of our population, an exponential increase in incidence is expected over the next few decades.
Ignacio Cruz-Gonzalez +5 more
+4 more sources
Transcatheter Occlusion of the Left Atrial Appendage
Interventional Cardiology Clinics, 2013The left atrial appendage is a primary source of thrombi in patients with nonvalvular atrial fibrillation. Transcatheter left atrial appendage occlusion/exclusion is a novel technology with the potential as an alternative approach for lifelong anticoagulation to prevent potential catastrophic embolic stroke. This article discusses important evaluation,
Mamoo, Nakamura, Saibal, Kar
openaire +2 more sources
Left Atrial Appendage Occlusion in the Spotlight
JACC: Clinical Electrophysiology, 2015![Figure][1] The significance of the left atrial appendage (LAA) as the predominant source of cardiac thromboemboli associated with nonvalvular atrial fibrillation (AF) and its increasingly recognized direct role in arrhythmogenesis has led to intensive clinical investigation of the LAA ...
openaire +2 more sources
Hemodynamic effects of left atrial appendage occlusion
Journal of Interventional Cardiac Electrophysiology, 2021Percutaneous left atrial appendage occlusion (LAAO) devices have emerged as alternatives to anticoagulation for embolic stroke prevention in patients with non-valvular atrial fibrillation (NVAF). The left atrial appendage is known to produce vasoactive neuroendocrine hormones involved in cardiovascular homeostasis.
Esseim Sharma +8 more
openaire +2 more sources
LEFT ATRIAL APPENDAGE OCCLUSION FOLLOWING LEFT ATRIAL APPENDAGE ISOLATION
Journal of the American College of Cardiology, 2018LAA isolation is an important adjunctive ablation strategy in patients with non-paroxysmal AF. Given the high prevalence of poor contractile function of the LAA, the risk of stroke in this cohort is high and OAC is recommended despite maintenance of SR.
Varuna Gadiyaram +14 more
openaire +1 more source
Left Atrial Appendage Occlusion for Stroke Prevention
Progress in Cardiovascular Diseases, 2017More than 2.3 million adults in the United States have atrial fibrillation (AF), which exposes them to a 5-fold increased risk of stroke. The left atrial appendage (LAA) appears to be the source of thrombus formation in the vast majority of these patients.
Arijit, Chanda, John P, Reilly
openaire +2 more sources
Left Atrial Appendage Occlusion: A Narrative Review
Journal of Cardiothoracic and Vascular Anesthesia, 2019Left atrial appendage occlusion (LAAO) is a proposed alternative to oral anticoagulation in reducing stroke in patients with atrial fibrillation. It is suggested that LAAO is most suitable in patients at increased risk of stroke or bleeding or with contraindication to pharmacologic intervention.
Ali Alsagheir +3 more
openaire +2 more sources
Demystifying Left Atrial Appendage Occlusion
Cardiac Electrophysiology Clinics, 2023Emily P, Zeitler, Jordan M, Prutkin
openaire +2 more sources